New design: reduced height of the device and a sliding back cover provide more options for placing the device on work surfaces.Width: 33 cm × Depth: 56 cm × Height: 36 cm Width: 13 inches × Depth: 22 inches × Height: 14 inches ± 0.3 ° C well to after 10 seconds after reaching the targetĬFX Opus 96: 6 LED with filters CFX Opus 384: 5 LED with filtersĬFX Opus 96: 6 photodiodes with filters CFX Opus 384: 5 photodiodes with filtersĬFX Opus 96: 450-684 nm CFX Opus 384: 450-650 nmĬFX Opus 96: 510-730 nm CFX Opus 384: 515-690 nmĭetects 1 copy of the target sequence in human DNAĬFX Opus 96: 1-50 μl (10-50 recommended) CFX Opus 384: 1-30 μl (5-30 recommended) Sensitivity – 1 copy of target sequenceĬFX Opus 96: 5 ° C / s CFX Opus 384: 2.5 ° C / sĬFX Opus 96: 3.3 ° C / s CFX Opus 384: 2 ° C / s.But the Opus models offer better usability and comes inbuilt with different features that suit commercial, academic, and biopharma labs. The CFX Opus Bio Rad comes in two models and with the same optical designs used in Bio Rad’s CFX portfolio products. These machines were used in genomic testing, research, pathogen detection, and infectious disease testing.
This machine from Bio Rad is the advanced version of the company’s previous PCR machine, CFX. "The addition of BR.io cloud connectivity offers customers a simplified qPCR experience and demonstrate Bio-Rad’s commitment to developing robust solutions to meet customers’ needs within the ever-evolving landscape of genomics research and diagnostics," she said. "The CFX Opus Systems expand the Bio-Rad family of life science tools, helping our customers find answers to complex biological questions," said Annette Tumolo, Bio-Rad Executive Vice President and President Life Science Group. This PCR machine helps conduct translational and basic research, quality control, and process development. Another addition to its list is the CFX Opus Bio Rad system with enhanced performance and improved connectivity. The company launched sever PCR machines in the CFX series.
New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases."By identifying those who test positive for the virus, individuals can be quarantined and receive treatment more quickly, helping to contain the spread of this disease." "We are pleased our CFX96 Dx Real-Time PCR System is now available for COVID-19 testing in US markets," said Annette Tumolo, Bio-Rad Executive Vice President, President, Life Science Group. The CFX96 Dx Real-Time System joins other Bio-Rad products that are being used for the detection of COVID-19, including the company’s SARS-CoV-2 Droplet Digital PCR (ddPCR) Kit Platelia SARS-CoV-2 Total Ab assay and the SARS-CoV-2 Standard, which is used to support laboratory assay validation of COVID-19 testing. The FDA listing now extends access to the instrument to assay developers and testing laboratories in the US. The system has also met the CE mark requirements for IVD use in Europe and is registered with regulatory bodies for IVD use in many other countries. Throughout the COVID-19 pandemic, the CFX96 Dx Real-Time PCR System has been used by laboratories outside the US that require an IVD platform to detect SARS-CoV-2. Bio-Rad Laboratories, Inc.’s (Hercules, CA, USA) CFX96 Dx Real-Time PCR System has been listed with the US Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.
0 kommentar(er)
